Denosumab News
Most Popular Denosumab Story
Amgen keeping bone drug to itself
Amgen CEO, Keven Sharer (photo), said yesterday that he does not foresee the company collaborating... Read more...
Latest Headlines
- July 28, 2009
- November 10, 2008
- November 7, 2008
- September 10, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
